Infliximab treatment reduces complement activation in patients with rheumatoid arthritis

Background: Tumour necrosis factor (TNF) blocking agents decrease C reactive protein (CRP) levels in rheumatoid arthritis (RA). It has been shown that CRP may contribute to complement activation in RA. Objective: To assess the effect of intravenous infliximab treatment on complement activation, espe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Familian, A, Voskuyl, A, van Mierlo, G J, Heijst, H, Twisk, J, Dijkmans, B, Hack, C
Formato: Artigo
Idioma:Inglês
Publicado: 2005
Assuntos:
Extended Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755560/
https://ncbi.nlm.nih.gov/pubmed/15958758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.029124
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares